COURTNI ANDRUS: Open Payments
NPI 1982903894 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 17 payments from 9 companies in 2025. Trend: 2023 $16 · 2024 $176 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $174 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $80 |
| Novo Nordisk Inc | 3 | $62 |
| ABBVIE INC. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $23 |
| PFIZER INC. | 1 | $16 |
| Abbott Laboratories | 1 | $16 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
Products named: BREZTRI, Kerendia, Wegovy, VRAYLAR, AIRSUPRA, TRINTELLIX, REXULTI, Rybelsus.
Industry payments across TX — which companies pay providers there.
